ABOS Acumen Pharmaceuticals | $1.23
+0.1% | 3/28/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $15.00 -> $11.00 | Medium | View details for HC Wainwright rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 3/28/2025 |
IVA Inventiva | $2.97
+3.1% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 3/28/2025 |
GEVO Gevo | $1.24
-2.0% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | Medium | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 3/28/2025 |
ICCM IceCure Medical | $1.09
-1.4% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $2.50 -> $2.50 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 3/28/2025 |
USAS Americas Silver | $0.56
+1.9% | 3/28/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $0.90 -> $1.00 | N/A | View details for HC Wainwright rating of Americas Silver (NYSEAMERICAN:USAS) on 3/28/2025 |
WKSP Worksport | $3.26
-2.8% | 3/28/2025 | Target Raised by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $1.50 -> $11.50 | Low | View details for HC Wainwright rating of Worksport (NASDAQ:WKSP) on 3/28/2025 |
SVRA Savara | $2.76
-0.7% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $6.00 -> $6.00 | Low | View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 3/28/2025 |
SNSE Sensei Biotherapeutics | $0.60
+40.0% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Sensei Biotherapeutics (NASDAQ:SNSE) on 3/28/2025 |
DTIL Precision BioSciences | $4.71
+3.6% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | High | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 3/28/2025 |
EDAP Edap Tms | $2.27
+2.0% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $19.00 -> $19.00 | Low | View details for HC Wainwright rating of Edap Tms (NASDAQ:EDAP) on 3/28/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
IPHA Innate Pharma | $1.98
+0.5% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $11.50 -> $11.50 | High | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 3/28/2025 |
TPST Tempest Therapeutics | $0.80
-4.4% | 3/28/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $47.00 -> $16.00 | High | View details for HC Wainwright rating of Tempest Therapeutics (NASDAQ:TPST) on 3/28/2025 |
XOMA XOMA | $21.26
+0.6% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $104.00 -> $104.00 | Low | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 3/28/2025 |
FEMY Femasys | $1.37
+2.2% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/28/2025 |
DRRX DURECT | $0.81
| 3/27/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of DURECT (NASDAQ:DRRX) on 3/27/2025 |
BITF Bitfarms | $0.92
-3.9% | 3/27/2025 | Target Lowered by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $4.00 -> $3.50 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 3/27/2025 |
STTK Shattuck Labs | $1.18
+3.5% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Neutral -> Neutral | | High | View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 3/27/2025 |
PDSB PDS Biotechnology | $1.22
-2.8% | 3/27/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $13.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/27/2025 |
CAN Canaan | $0.90
-2.2% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 3/27/2025 |
AIRJ Montana Technologies | $5.26
-0.7% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Montana Technologies (NASDAQ:AIRJ) on 3/27/2025 |
USIO Usio | $1.56
-0.3% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Usio (NASDAQ:USIO) on 3/27/2025 |
ITRG Integra Resources | $1.35
+1.9% | 3/27/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.00 -> $2.75 | N/A | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 3/27/2025 |
XFOR X4 Pharmaceuticals | $0.26
-2.6% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $1.50 -> $1.50 | Medium | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 3/27/2025 |
LPTX Leap Therapeutics | $0.34
-8.2% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Leap Therapeutics (NASDAQ:LPTX) on 3/27/2025 |
RNXT RenovoRx | $1.02
-0.3% | 3/27/2025 | Initiated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy | $3.00 | Low | View details for HC Wainwright rating of RenovoRx (NASDAQ:RNXT) on 3/27/2025 |
NKTX Nkarta | $2.02
+2.3% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of Nkarta (NASDAQ:NKTX) on 3/27/2025 |
EXEL Exelixis | $36.58
-0.7% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 3/27/2025 |
ZNTL Zentalis Pharmaceuticals | $1.70
-3.5% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 3/27/2025 |
NYXH Nyxoah | $7.87
-1.6% | 3/26/2025 | Target Lowered by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $15.00 | High | View details for HC Wainwright rating of Nyxoah (NASDAQ:NYXH) on 3/26/2025 |
VANI Vivani Medical | $1.11
-3.5% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 3/26/2025 |
WVE Wave Life Sciences | $8.90
-1.2% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Wave Life Sciences (NASDAQ:WVE) on 3/26/2025 |
VKTX Viking Therapeutics | $26.09
-0.1% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | Medium | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2025 |
ATOS Atossa Therapeutics | $0.69
-1.1% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 3/26/2025 |
FUFU BitFuFu | $4.77
-3.1% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of BitFuFu (NASDAQ:FUFU) on 3/26/2025 |
CRVS Corvus Pharmaceuticals | $3.36
-0.4% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst S. Lee | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/26/2025 |
ACRV Acrivon Therapeutics | $2.33
-7.4% | 3/26/2025 | Target Lowered by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $22.00 -> $19.00 | High | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 3/26/2025 |
IMNN Imunon | $1.10
-3.9% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 3/26/2025 |
ARTV Artiva Biotherapeutics | $3.63
-0.3% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 3/26/2025 |
ALMS Alumis | $5.00
+6.4% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/26/2025 |
LXEO Lexeo Therapeutics | $4.14
+0.6% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $23.00 -> $23.00 | High | View details for HC Wainwright rating of Lexeo Therapeutics (NASDAQ:LXEO) on 3/26/2025 |
Partner with Elon Musk on Project Colossus… Before May 1st (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
MURA Mural Oncology | $1.30
-4.0% | 3/26/2025 | Target Lowered by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $18.00 -> $6.00 | High | View details for HC Wainwright rating of Mural Oncology (NASDAQ:MURA) on 3/26/2025 |
IVVD Invivyd | $0.63
+2.5% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 3/26/2025 |
SMTI Sanara MedTech | $30.96
+4.5% | 3/26/2025 | Target Raised by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $50.00 -> $51.00 | High | View details for HC Wainwright rating of Sanara MedTech (NASDAQ:SMTI) on 3/26/2025 |
FNV Franco-Nevada | $157.55
+0.2% | 3/26/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $165.00 -> $180.00 | Medium | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 3/26/2025 |
SAVA Cassava Sciences | $1.74
+2.1% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst V. Bernardino | Neutral -> Neutral | $2.00 -> $2.00 | High | View details for HC Wainwright rating of Cassava Sciences (NASDAQ:SAVA) on 3/25/2025 |
GNLX Genelux | $2.95
-7.8% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 3/25/2025 |
ATNM Actinium Pharmaceuticals | $1.91
+0.8% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 3/25/2025 |
BOLT Bolt Biotherapeutics | $0.46
+4.0% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Neutral -> Neutral | | High | View details for HC Wainwright rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 3/25/2025 |
OPT Opthea | $3.41
+7.2% | 3/25/2025 | Downgraded by | HC Wainwright | Analyst Matthew Caufield | Buy -> Neutral | $12.00 -> $2.00 | Low | View details for HC Wainwright rating of Opthea (NASDAQ:OPT) on 3/25/2025 |
MAG MAG Silver | $16.82
+1.1% | 3/25/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $21.00 -> $22.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 3/25/2025 |
CGON CG Oncology | $26.35
-2.2% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $75.00 -> $75.00 | Medium | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 3/25/2025 |
LRMR Larimar Therapeutics | $2.28
-5.0% | 3/25/2025 | Target Raised by | HC Wainwright | Analyst E. White | Buy -> Buy | $15.00 -> $16.00 | Medium | View details for HC Wainwright rating of Larimar Therapeutics (NASDAQ:LRMR) on 3/25/2025 |
MGNX MacroGenics | $1.46
-1.7% | 3/25/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | $4.00 -> $2.00 | High | View details for HC Wainwright rating of MacroGenics (NASDAQ:MGNX) on 3/25/2025 |
ANIX Anixa Biosciences | $3.04
-1.3% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 3/25/2025 |
VERV Verve Therapeutics | $5.33
-1.3% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 3/25/2025 |
NGNE Neurogene | $15.00
-2.2% | 3/25/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $55.00 -> $50.00 | High | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 3/25/2025 |
PLUG Plug Power | $1.41
-2.4% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Plug Power (NASDAQ:PLUG) on 3/24/2025 |
CLNN Clene | $3.19
+0.2% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | High | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 3/24/2025 |
BMEA Biomea Fusion | $2.47
-0.8% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 3/24/2025 |
MBRX Moleculin Biotech | $1.03
-1.9% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Moleculin Biotech (NASDAQ:MBRX) on 3/24/2025 |
UBX Unity Biotechnology | $1.20
+1.7% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $8.00 -> $4.00 | N/A | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 3/24/2025 |
AURA Aura Biosciences | $6.02
+0.4% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 3/24/2025 |
ASMB Assembly Biosciences | $10.97
+1.5% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Neutral -> Neutral | | High | View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 3/24/2025 |
ABEO Abeona Therapeutics | $5.02
-0.5% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 3/24/2025 |
BNTC Benitec Biopharma | $13.67
-2.5% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Benitec Biopharma (NASDAQ:BNTC) on 3/24/2025 |
CGTX Cognition Therapeutics | $0.44
-2.2% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $6.00 -> $5.00 | High | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/24/2025 |
ENLV Enlivex Therapeutics | $1.05
+3.5% | 3/24/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $6.00 -> $7.00 | High | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 3/24/2025 |
RMTI Rockwell Medical | $1.22
-1.6% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $7.00 -> $3.00 | High | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 3/24/2025 |
RYTM Rhythm Pharmaceuticals | $53.50
+0.0% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 3/24/2025 |
FLUX Flux Power | $1.97
+1.3% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $15.00 -> $8.00 | High | View details for HC Wainwright rating of Flux Power (NASDAQ:FLUX) on 3/24/2025 |
PHUN Phunware | $3.05
-1.5% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst S. Buck | Neutral -> Neutral | $6.00 -> $3.00 | Medium | View details for HC Wainwright rating of Phunware (NASDAQ:PHUN) on 3/24/2025 |
COLL Collegium Pharmaceutical | $29.52
-1.5% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $50.00 -> $50.00 | High | View details for HC Wainwright rating of Collegium Pharmaceutical (NASDAQ:COLL) on 3/24/2025 |
VSTM Verastem | $6.61
+3.3% | 3/24/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $7.00 -> $10.00 | Medium | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 3/24/2025 |
MTVA MetaVia | $1.56
-1.9% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of MetaVia (NASDAQ:MTVA) on 3/21/2025 |
BRNS Barinthus Biotherapeutics | $1.03
-3.3% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 3/21/2025 |
YMAB Y-mAbs Therapeutics | $4.90
-1.2% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $22.00 -> $12.00 | Medium | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 3/21/2025 |
LGVN Longeveron | $1.72
-0.2% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 3/21/2025 |
EBS Emergent BioSolutions | $4.73
-3.8% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 3/21/2025 |
ERAS Erasca | $1.55
+4.4% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 3/21/2025 |
MOGO Mogo | $0.99
-0.1% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $6.00 -> $4.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 3/21/2025 |
IDN Intellicheck | $2.62
+0.4% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 3/21/2025 |
PPTA Perpetua Resources | $11.15
+0.7% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $25.00 -> $28.00 | High | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 3/21/2025 |
UAMY United States Antimony | $2.39
+2.0% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $2.50 -> $2.60 | High | View details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 3/21/2025 |
AMPX Amprius Technologies | $2.92
-0.9% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Amprius Technologies (NYSE:AMPX) on 3/21/2025 |
CBUS Cibus | $2.02
-1.0% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cibus (NASDAQ:CBUS) on 3/21/2025 |
VALN Valneva | $7.33
+2.4% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $17.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 3/21/2025 |
IFRX InflaRx | $1.19
-4.5% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 3/21/2025 |
ELEV Elevation Oncology | $0.27
+1.9% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $1.00 | High | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 3/21/2025 |
VOR Vor Biopharma | $0.76
-0.2% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $17.50 -> $13.00 | High | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 3/21/2025 |
CNTX Context Therapeutics | $0.72
-8.5% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Context Therapeutics (NASDAQ:CNTX) on 3/21/2025 |
Partner with Elon Musk on Project Colossus… Before May 1st (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
ELVN Enliven Therapeutics | $21.36
-0.7% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $37.00 -> $39.00 | High | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 3/21/2025 |
OPTN OptiNose | $9.16
-0.2% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Neutral | $18.00 -> $9.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 3/21/2025 |
AVTX Avalo Therapeutics | $8.38
+0.2% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | Low | View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 3/20/2025 |
ESPR Esperion Therapeutics | $1.59
-1.6% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 3/20/2025 |
PHAR Pharming Group | $8.50
-3.2% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $37.00 -> $37.00 | Low | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 3/20/2025 |
PGEN Precigen | $1.60
-0.9% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 3/20/2025 |
SCPH scPharmaceuticals | $3.01
+0.1% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of scPharmaceuticals (NASDAQ:SCPH) on 3/20/2025 |
MDWD MediWound | $16.75
-1.4% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 3/20/2025 |
KRRO Korro Bio | $18.49
+0.6% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $115.00 -> $115.00 | High | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 3/20/2025 |
ALMS Alumis | $5.00
+6.4% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $19.00 -> $15.00 | High | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/20/2025 |
LQDA Liquidia | $15.46
+1.5% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $29.00 -> $29.00 | High | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 3/20/2025 |
PMVP PMV Pharmaceuticals | $1.13
-2.6% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 3/20/2025 |
NRXP NRx Pharmaceuticals | $2.08
+0.5% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/20/2025 |
FEMY Femasys | $1.37
+2.2% | 3/19/2025 | Target Raised by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $15.00 | Medium | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/19/2025 |
DTIL Precision BioSciences | $4.71
+3.6% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | Low | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 3/19/2025 |
ATAI Atai Life Sciences | $1.54
-1.8% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 3/19/2025 |
IMVT Immunovant | $18.45
-1.8% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $51.00 -> $51.00 | High | View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 3/19/2025 |
MUX McEwen Mining | $8.08
+0.4% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of McEwen Mining (NYSE:MUX) on 3/19/2025 |
STOK Stoke Therapeutics | $7.47
+0.9% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $47.00 -> $47.00 | High | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 3/19/2025 |
REE REE Automotive | $3.40
-7.0% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 3/19/2025 |
GAU Galiano Gold | $1.27
+0.4% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.80 -> $2.80 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 3/19/2025 |
OLMA Olema Pharmaceuticals | $4.16
+0.5% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/19/2025 |
OABI OmniAb | $2.45
+0.6% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of OmniAb (NASDAQ:OABI) on 3/19/2025 |
XOMA XOMA | $21.26
+0.6% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $104.00 -> $104.00 | High | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 3/19/2025 |
TRVI Trevi Therapeutics | $6.63
+2.5% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $12.50 -> $12.50 | High | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/19/2025 |
ETON Eton Pharmaceuticals | $13.26
-0.9% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $33.00 -> $33.00 | Low | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 3/19/2025 |
PYXS Pyxis Oncology | $1.06
-2.8% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 3/19/2025 |
ABSI Absci | $2.83
+0.8% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 3/19/2025 |
DMAC DiaMedica Therapeutics | $4.17
+2.1% | 3/19/2025 | Target Raised by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $7.00 -> $10.00 | Low | View details for HC Wainwright rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/19/2025 |
INO Inovio Pharmaceuticals | $1.73
-2.0% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Neutral -> Neutral | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Inovio Pharmaceuticals (NASDAQ:INO) on 3/19/2025 |
ASRT Assertio | $0.73
+0.6% | 3/19/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $4.00 -> $3.50 | High | View details for HC Wainwright rating of Assertio (NASDAQ:ASRT) on 3/19/2025 |
SRPT Sarepta Therapeutics | $71.53
-0.4% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | High | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/19/2025 |
PRME Prime Medicine | $2.00
-0.3% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Prime Medicine (NYSE:PRME) on 3/19/2025 |
CRBU Caribou Biosciences | $0.98
-0.7% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $9.00 -> $9.00 | High | View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 3/19/2025 |
CATX Perspective Therapeutics | $2.30
| 3/19/2025 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Perspective Therapeutics (NYSE:CATX) on 3/19/2025 |
ALLO Allogene Therapeutics | $1.56
-0.3% | 3/19/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $9.00 -> $8.00 | High | View details for HC Wainwright rating of Allogene Therapeutics (NASDAQ:ALLO) on 3/19/2025 |
OPK OPKO Health | $1.73
-0.9% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 3/19/2025 |
ATNM Actinium Pharmaceuticals | $1.91
+0.8% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 3/18/2025 |
INKT MiNK Therapeutics | $9.09
+6.9% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $35.00 -> $35.00 | High | View details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 3/18/2025 |
HROW Harrow | $28.57
+2.5% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $57.00 -> $57.00 | High | View details for HC Wainwright rating of Harrow (NASDAQ:HROW) on 3/18/2025 |
BTM Bitcoin Depot | $1.47
-0.7% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Bitcoin Depot (NASDAQ:BTM) on 3/18/2025 |
FGEN FibroGen | $0.31
-7.0% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst M. Keller | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of FibroGen (NASDAQ:FGEN) on 3/18/2025 |
ENTX Entera Bio | $1.79
-1.4% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 3/18/2025 |
PLRX Pliant Therapeutics | $1.51
-0.3% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral -> Neutral | | High | View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 3/18/2025 |
ELBM Electra Battery Materials | $1.17
+3.1% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.40 -> $2.40 | High | View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 3/18/2025 |
EU enCore Energy | $1.37
-1.8% | 3/18/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.00 -> $2.75 | Low | View details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 3/18/2025 |
USAS Americas Silver | $0.56
+1.9% | 3/18/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.00 -> $0.90 | N/A | View details for HC Wainwright rating of Americas Silver (NYSEAMERICAN:USAS) on 3/18/2025 |
SUUN SolarBank | $2.69
-0.9% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of SolarBank (NASDAQ:SUUN) on 3/18/2025 |
ACOG Alpha Cognition | $5.31
-3.8% | 3/18/2025 | Initiated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy | $20.00 | Medium | View details for HC Wainwright rating of Alpha Cognition (NASDAQ:ACOG) on 3/18/2025 |
ALT Altimmune | $5.51
-1.1% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 3/18/2025 |
Trump’s Final Plan (Ad) Presidential insider exposes shocking plot to reshape U.S. economy:
The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed. Click here for the full story. |
GOSS Gossamer Bio | $1.21
+3.9% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 3/18/2025 |
BLTE Belite Bio | $65.80
+0.9% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $100.00 -> $100.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 3/18/2025 |
SANA Sana Biotechnology | $1.84
-0.5% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 3/18/2025 |
AGEN Agenus | $1.60
-3.6% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 3/18/2025 |
MDAI Spectral AI | $1.10
-14.1% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $3.50 -> $3.50 | High | View details for HC Wainwright rating of Spectral AI (NASDAQ:MDAI) on 3/18/2025 |
OKUR OnKure Therapeutics | $4.57
-3.7% | 3/18/2025 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $40.00 -> $34.00 | High | View details for HC Wainwright rating of OnKure Therapeutics (NASDAQ:OKUR) on 3/18/2025 |
BDTX Black Diamond Therapeutics | $1.61
-3.9% | 3/18/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $11.00 -> $12.00 | High | View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/18/2025 |
CAPR Capricor Therapeutics | $11.66
-1.3% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $77.00 -> $77.00 | High | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 3/17/2025 |
DYN Dyne Therapeutics | $11.94
+6.0% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 3/17/2025 |
DRTS Alpha Tau Medical | $2.74
+4.6% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 3/17/2025 |
NXTC NextCure | $0.54
+0.8% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 3/17/2025 |
MIST Milestone Pharmaceuticals | $0.86
-61.9% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 3/17/2025 |
RNA Avidity Biosciences | $32.54
+1.5% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $72.00 -> $72.00 | High | View details for HC Wainwright rating of Avidity Biosciences (NASDAQ:RNA) on 3/17/2025 |
STRO Sutro Biopharma | $0.75
-2.7% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Neutral | $12.00 -> $2.00 | High | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 3/17/2025 |
BTBT Bit Digital | $2.17
-4.6% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 3/17/2025 |
VERI Veritone | $2.71
-1.1% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Veritone (NASDAQ:VERI) on 3/17/2025 |
ANIP ANI Pharmaceuticals | $68.13
+1.4% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $94.00 -> $94.00 | High | View details for HC Wainwright rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/17/2025 |
GANX Gain Therapeutics | $2.03
-1.9% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 3/17/2025 |
RGNX REGENXBIO | $7.90
-0.2% | 3/17/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $36.00 -> $34.00 | Medium | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 3/17/2025 |
ZNTL Zentalis Pharmaceuticals | $1.70
-3.5% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 3/17/2025 |
RLYB Rallybio | $0.69
+8.3% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 3/17/2025 |
ACTU Actuate Therapeutics | $7.43
-2.0% | 3/17/2025 | Initiated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy | $20.00 | Low | View details for HC Wainwright rating of Actuate Therapeutics (NASDAQ:ACTU) on 3/17/2025 |
NRXP NRx Pharmaceuticals | $2.08
+0.5% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/14/2025 |
CADL Candel Therapeutics | $6.81
-2.0% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 3/14/2025 |
AKBA Akebia Therapeutics | $1.92
-0.8% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | High | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 3/14/2025 |
INAB IN8bio | $0.21
-1.5% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $6.00 | Medium | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 3/14/2025 |
RNAC Cartesian Therapeutics | $14.51
-2.5% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $45.00 -> $40.00 | High | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 3/14/2025 |
PRQR ProQR Therapeutics | $1.45
+1.0% | 3/14/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $10.00 -> $12.00 | High | View details for HC Wainwright rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2025 |
ACIU AC Immune | $1.98
-1.0% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 3/14/2025 |
KALV KalVista Pharmaceuticals | $12.24
-0.9% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 3/14/2025 |
VIGL Vigil Neuroscience | $1.84
-2.6% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $17.00 -> $14.00 | High | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 3/14/2025 |
EMX EMX Royalty | $2.13
+0.7% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.00 -> $5.00 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 3/14/2025 |
AMTX Aemetis | $1.89
-3.8% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Aemetis (NASDAQ:AMTX) on 3/14/2025 |
SOL Emeren Group | $1.60
-1.2% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Emeren Group (NYSE:SOL) on 3/14/2025 |
BLNK Blink Charging | $0.93
-0.8% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Sameer Joshi | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 3/14/2025 |
PHAR Pharming Group | $8.50
-3.2% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $37.00 -> $37.00 | Medium | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 3/14/2025 |
ATYR Atyr PHARMA | $3.20
-1.8% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $35.00 -> $35.00 | Medium | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 3/14/2025 |
TRML Tourmaline Bio | $16.89
+1.0% | 3/14/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $49.00 -> $50.00 | High | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 3/14/2025 |
RGLS Regulus Therapeutics | $1.65
+9.7% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/14/2025 |
IPA ImmunoPrecise Antibodies | $0.40
-8.2% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 3/14/2025 |
PDSB PDS Biotechnology | $1.22
-2.8% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/13/2025 |
IBRX ImmunityBio | $3.30
-1.8% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 3/13/2025 |
FEMY Femasys | $1.37
+2.2% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/13/2025 |
NKTR Nektar Therapeutics | $0.78
+2.5% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $6.50 -> $6.50 | High | View details for HC Wainwright rating of Nektar Therapeutics (NASDAQ:NKTR) on 3/13/2025 |
UEC Uranium Energy | $5.11
-0.1% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $12.25 -> $12.25 | N/A | View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 3/13/2025 |
VYGR Voyager Therapeutics | $3.73
-0.2% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/13/2025 |
AEYE AudioEye | $11.46
-2.6% | 3/13/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $37.00 -> $22.00 | High | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 3/13/2025 |
VANI Vivani Medical | $1.11
-3.5% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 3/13/2025 |
OCS Oculis | $19.62
-0.2% | 3/13/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $30.00 -> $29.00 | Low | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 3/13/2025 |
ZVRA Zevra Therapeutics | $7.96
| 3/13/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/13/2025 |
Trump’s Final Plan (Ad) Presidential insider exposes shocking plot to reshape U.S. economy:
The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed. Click here for the full story. |
LYEL Lyell Immunopharma | $0.58
-2.6% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $1.00 -> $1.00 | High | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 3/13/2025 |
EDSA Edesa Biotech | $2.53
-0.6% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $21.00 -> $21.00 | Medium | View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 3/13/2025 |
ECOR electroCore | $6.69
-6.6% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of electroCore (NASDAQ:ECOR) on 3/13/2025 |
CATX Perspective Therapeutics | $2.30
| 3/13/2025 | Initiated by | HC Wainwright | Analyst Robert Burns | Buy | $10.00 | High | View details for HC Wainwright rating of Perspective Therapeutics (NYSE:CATX) on 3/13/2025 |
ASM Avino Silver & Gold Mines | $1.95
-0.8% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.90 -> $2.20 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/12/2025 |
ASM Avino Silver & Gold Mines | $1.95
+2.4% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.90 -> $2.20 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/12/2025 |
OPK OPKO Health | $1.73
-0.9% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 3/12/2025 |
CLNN Clene | $3.19
+0.2% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 3/12/2025 |
LEGN Legend Biotech | $34.92
-1.3% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $73.00 -> $75.00 | Medium | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 3/12/2025 |
HUMA Humacyte | $1.95
-3.1% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 3/12/2025 |
EVEX EVE | $3.46
-6.4% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of EVE (NYSE:EVEX) on 3/12/2025 |
RDW Redwire | $9.40
-4.7% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $26.00 -> $26.00 | High | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 3/12/2025 |
EXK Endeavour Silver | $4.51
-1.2% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.00 -> $7.25 | High | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 3/12/2025 |
DNTH Dianthus Therapeutics | $19.82
+8.5% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/12/2025 |
MYO Myomo | $4.98
-1.9% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $7.50 -> $9.50 | N/A | View details for HC Wainwright rating of Myomo (NYSEAMERICAN:MYO) on 3/12/2025 |
IMCR Immunocore | $30.34
+3.0% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $100.00 -> $100.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 3/12/2025 |
GERN Geron | $1.65
+0.2% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Geron (NASDAQ:GERN) on 3/12/2025 |
AGEN Agenus | $1.60
-3.6% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 3/12/2025 |
ATOS Atossa Therapeutics | $0.69
-1.1% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 3/12/2025 |
MURA Mural Oncology | $1.30
-4.0% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for HC Wainwright rating of Mural Oncology (NASDAQ:MURA) on 3/12/2025 |
HOWL Werewolf Therapeutics | $1.05
-1.9% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for HC Wainwright rating of Werewolf Therapeutics (NASDAQ:HOWL) on 3/12/2025 |
CRBP Corbus Pharmaceuticals | $5.76
-2.8% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $75.00 -> $50.00 | Low | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/12/2025 |
BWAY BrainsWay | $9.68
+2.0% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 3/12/2025 |
ZYXI Zynex | $2.37
-2.6% | 3/12/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $17.00 -> $15.00 | High | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 3/12/2025 |
LFMD LifeMD | $5.55
-0.8% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $12.00 -> $14.00 | Medium | View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 3/12/2025 |
SGMT Sagimet Biosciences | $3.79
-4.2% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $32.00 -> $32.00 | Low | View details for HC Wainwright rating of Sagimet Biosciences (NASDAQ:SGMT) on 3/11/2025 |
JSPR Jasper Therapeutics | $4.83
-0.2% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/11/2025 |
ATXS Astria Therapeutics | $5.99
-2.0% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/11/2025 |
CORZ Core Scientific | $7.82
-0.8% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for HC Wainwright rating of Core Scientific (NASDAQ:CORZ) on 3/11/2025 |
OLMA Olema Pharmaceuticals | $4.16
+0.5% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/11/2025 |
AA Alcoa | $31.91
-0.2% | 3/11/2025 | Target Raised by | HC Wainwright | - | Buy | $90.00 | Low | View details for HC Wainwright rating of Alcoa (NYSE:AA) on 3/11/2025 |
ARVN Arvinas | $8.01
-0.4% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $81.00 -> $81.00 | High | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 3/11/2025 |
VKTX Viking Therapeutics | $26.09
-0.1% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | High | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/11/2025 |
ATNM Actinium Pharmaceuticals | $1.91
+0.8% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 3/11/2025 |
ALGS Aligos Therapeutics | $9.57
-1.0% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $75.00 -> $70.00 | Low | View details for HC Wainwright rating of Aligos Therapeutics (NASDAQ:ALGS) on 3/11/2025 |
FNV Franco-Nevada | $157.55
+0.2% | 3/11/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $155.00 -> $165.00 | Low | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 3/11/2025 |
WWR Westwater Resources | $0.57
+2.1% | 3/11/2025 | Initiated by | HC Wainwright | Analyst Heiko Ihle | Buy | $2.50 | High | View details for HC Wainwright rating of Westwater Resources (NASDAQ:WWR) on 3/11/2025 |
INUV Inuvo | $0.40
+0.9% | 3/11/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $2.00 | Low | View details for HC Wainwright rating of Inuvo (NYSE:INUV) on 3/11/2025 |
CHRS Coherus BioSciences | $0.86
+0.5% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 3/11/2025 |
TNYA Tenaya Therapeutics | $0.67
-3.6% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $18.00 -> $5.00 | High | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/11/2025 |
LCTX Lineage Cell Therapeutics | $0.49
-1.9% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2025 |
CKPT Checkpoint Therapeutics | $4.04
+0.1% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Neutral | $4.10 | Low | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/11/2025 |
INZY Inozyme Pharma | $0.98
-1.7% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Inozyme Pharma (NASDAQ:INZY) on 3/11/2025 |
LFWD ReWalk Robotics | $1.87
-0.8% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 3/11/2025 |
ENGN enGene | $4.79
+2.8% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 3/11/2025 |
URGN UroGen Pharma | $11.40
-1.0% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $64.00 -> $55.00 | High | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 3/11/2025 |
FENC Fennec Pharmaceuticals | $6.46
-0.2% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/11/2025 |
TRVI Trevi Therapeutics | $6.63
+2.5% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $7.50 -> $12.50 | High | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/10/2025 |
ONCY Oncolytics Biotech | $0.62
+0.6% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 3/10/2025 |
ZYME Zymeworks | $12.50
-0.1% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | $12.00 -> $13.00 | Low | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 3/10/2025 |
MLYS Mineralys Therapeutics | $14.66
-2.3% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 3/10/2025 |
BEAM Beam Therapeutics | $22.77
+2.6% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 3/10/2025 |
JAZZ Jazz Pharmaceuticals | $125.01
-4.5% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $200.00 -> $217.00 | Low | View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/10/2025 |
CDTX Cidara Therapeutics | $22.27
+6.9% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $24.00 -> $35.00 | High | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 3/10/2025 |
GEVO Gevo | $1.24
-2.0% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 3/10/2025 |
PTGX Protagonist Therapeutics | $49.54
+0.2% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $54.00 -> $54.00 | High | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/10/2025 |
ELEV Elevation Oncology | $0.27
+1.9% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 3/10/2025 |
SLDB Solid Biosciences | $4.34
-0.8% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $16.00 -> $20.00 | High | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 3/10/2025 |
UBX Unity Biotechnology | $1.20
+1.7% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 3/10/2025 |
ALMS Alumis | $5.00
+6.4% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $19.00 -> $19.00 | Low | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/10/2025 |
